1-3 of 3
Joseph Tariman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epigenomic Profiling of Multiple Myeloma Shows Widespread Stage Specific Alterations In DNA Methylation That Occur Early During Myelomagenesis

Christoph Heuck, MD, Jayesh Mehta, MD, Joseph Tariman, Natalie Pulliam, Yiting Yu, Tushar Bhagat, Sangeeta Nischal, Richard Meagher, Caroline Y. Hu, MD, Amit Verma, Seema B. Singhal, MD
Journal: Blood
Blood (2010) 116 (21): 784.
https://doi.org/10.1182/blood.V116.21.784.784
Published: 2010
Journal Articles

Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study

Clinical Trials & Observations Brief Report
Asher A. Chanan-Khan, Jonathan L. Kaufman, Jayesh Mehta, Paul G. Richardson, Kena C. Miller, Sagar Lonial, Nikhil C. Munshi, Robert Schlossman, Joseph Tariman, Seema Singhal
Journal: Blood
Blood (2006) 109 (6): 2604–2606.
https://doi.org/10.1182/blood-2006-09-046409
Published: 2006
Includes: Supplemental data
Journal Articles

High Plasma Cell Labeling Index (PCLI) Is an Adverse Prognostic Factor in Bortezomib-Treated Patients with Relapsed Myeloma.

Adi Gidron, Joseph Tariman, Munira Shabbir, Jayesh Mehta, Seema Singhal
Journal: Blood
Blood (2005) 106 (11): 3471.
https://doi.org/10.1182/blood.V106.11.3471.3471
Published: 2005